Hi Co., Ltd. announced that it participated in 'CES 2025' that opened on January 8th and unveiled AI-based digital healthcare services including Mind Check, which can diagnose depression and anxiety symptoms without a questionnaire.
CES, the world's largest information technology (IT) and consumer electronics show held in Las Vegas, USA, is where Hi, with support from the National IT Industry Promotion Agency (NIPA), operated a dedicated booth for digital healthcare this year, following its 2023 debut. Using this CES participation as a starting point for global expansion, Hi unveiled four innovative AI-based digital healthcare services, leveraging its latest technologies.
In particular, "Alzgard" is a dementia screening service based on digital biomarkers such as eye tracking, voice, and cognitive response tests. Clinical trials are currently underway at three university hospitals in Korea. Hi is currently in discussions for global clinical trials through 2026 and plans to continue collaboration with leading universities in the United States.
Additionally, 'Mind Check' has garnered attention as a service that can diagnose stress, depression, and anxiety in just 40 seconds using only HRV, a biometric data, without the hassle of a questionnaire, based on 1 million data points accumulated over the past three years.
In addition, 'Repeach', which can measure the severity of language impairment after stroke through voice analysis, and a service that can diagnose sarcopenia, which is emerging as a serious problem in the elderly, using a smartphone were also released.
"Since our founding in 2023, Hi has achieved significant success in digital healthcare clinical trials with two major U.S. medical schools," said Kim Jin-woo, CEO of Hi. "Participating in CES this year was an opportunity to share these achievements globally and provide a valuable platform for understanding customer feedback and demand for AI-based emotional disorder and dementia diagnostic services, which will fuel our global expansion."
- See more related articles
You must be logged in to post a comment.